Pseudoephedrine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
Pseudoephedrine | hsa00190 | Oxidative phosphorylation | 2.41E-03 | 6 | P13073, Q16718, O15239, Q7KZN9, P05496, O14521 | COX4I1, NDUFA5, NDUFA1, COX15, ATP5G1, SDHD | More | |
Pseudoephedrine | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 4.21E-02 | 1 | O75752 | B3GALNT1 | More | |
Pseudoephedrine | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4.21E-02 | 1 | O75752 | B3GALNT1 | More | |
Pseudoephedrine | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.87E-03 | 3 | P06865, O15466, Q9H4F1 | HEXA, ST8SIA5, ST6GALNAC4 | More | |
Pseudoephedrine | hsa00750 | Vitamin B6 metabolism | 2.80E-02 | 1 | O00764 | PDXK | More | |
Pseudoephedrine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Pseudoephedrine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
Pseudoephedrine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | |
Pseudoephedrine | hsa01240 | Biosynthesis of cofactors | 3.54E-03 | 4 | P48506, Q9BQB6, P14550, O00764 | GCLC, VKORC1, AKR1A1, PDXK | More | |
Pseudoephedrine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | |
Pseudoephedrine | hsa03010 | Ribosome | 1.14E-02 | 8 | P62753, P32969, P62829, P46776, P61927, P61513, P36578, P23396 | RPS6, RPL9, RPL23, RPL27A, RPL37, RPL37A, RPL4, RPS3 | More | |
Pseudoephedrine | hsa03020 | RNA polymerase | 2.12E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | |
Pseudoephedrine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Pseudoephedrine | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | |
Pseudoephedrine | hsa04022 | cGMP-PKG signaling pathway | 3.36E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04024 | cAMP signaling pathway | 4.24E-02 | 2 | Q02930, P15498 | CREB5, VAV1 | More | |
Pseudoephedrine | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 4 | P21453, Q9H228, P01375, Q13362 | S1PR1, EDG8, TNF, PPP2R5C | More | |
Pseudoephedrine | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | |
Pseudoephedrine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Pseudoephedrine | hsa04141 | Protein processing in endoplasmic reticulum | 6.42E-03 | 8 | P18848, Q15437, Q15436, P11142, Q9NXW2, Q9H3Z4, P07900, P14625 | ATF4, SEC23B, SEC23A, HSPA8, DNAJB12, DNAJC5, HSP90AA1, HSP90B1 | More | |
Pseudoephedrine | hsa04151 | PI3K-Akt signaling pathway | 8.21E-03 | 4 | Q5T1C6, P62879, Q16787, Q02930 | THEM4, GNB2, LAMA3, CREB5 | More | |
Pseudoephedrine | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
Pseudoephedrine | hsa04218 | Cellular senescence | 2.91E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | |
Pseudoephedrine | hsa04310 | Wnt signaling pathway | 1.57E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04360 | Axon guidance | 3.36E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04370 | VEGF signaling pathway | 6.73E-03 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04380 | Osteoclast differentiation | 2.24E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04610 | Complement and coagulation cascades | 2.78E-03 | 1 | P0C0L4 | C4A | More | |
Pseudoephedrine | hsa04612 | Antigen processing and presentation | 3.75E-04 | 8 | P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | |
Pseudoephedrine | hsa04613 | Neutrophil extracellular trap formation | 4.20E-02 | 5 | P04908, Q93077, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | |
Pseudoephedrine | hsa04621 | NOD-like receptor signaling pathway | 2.27E-02 | 9 | Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
Pseudoephedrine | hsa04625 | C-type lectin receptor signaling pathway | 2.02E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.53E-06 | 10 | Q13469, P01375, O60880, P20963, Q13241, P26718, O75015, P26717, Q14953, P26715 | NFATC2, TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | |
Pseudoephedrine | hsa04657 | IL-17 signaling pathway | 2.41E-02 | 4 | P19875, P14780, P80188, P01375 | CXCL2, MMP9, LCN2, TNF | More | |
Pseudoephedrine | hsa04658 | Th1 and Th2 cell differentiation | 3.36E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04659 | Th17 cell differentiation | 3.14E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04660 | T cell receptor signaling pathway | 2.24E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04662 | B cell receptor signaling pathway | 1.35E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04666 | Fc gamma R-mediated phagocytosis | 4.75E-02 | 2 | P15498, P29966 | VAV1, MARCKS | More | |
Pseudoephedrine | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | |
Pseudoephedrine | hsa04714 | Thermogenesis | 3.43E-04 | 11 | Q16539, Q92618, Q15418, P62753, P33121, P13073, Q7KZN9, O15239, Q16718, O14521, P05496 | MAPK14, ZNF516, RPS6KA1, RPS6, ACSL1, COX4I1, COX15, NDUFA1, NDUFA5, SDHD, ATP5G1 | More | |
Pseudoephedrine | hsa04720 | Long-term potentiation | 2.22E-02 | 4 | Q13557, P0DP24, Q15418, P18848 | CAMK2D, CALM2, RPS6KA1, ATF4 | More | |
Pseudoephedrine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
Pseudoephedrine | hsa04725 | Cholinergic synapse | 2.45E-02 | 2 | P62879, Q02930 | GNB2, CREB5 | More | |
Pseudoephedrine | hsa04728 | Dopaminergic synapse | 4.24E-02 | 2 | P62879, Q02930 | GNB2, CREB5 | More | |
Pseudoephedrine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | |
Pseudoephedrine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
Pseudoephedrine | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
Pseudoephedrine | hsa04921 | Oxytocin signaling pathway | 2.69E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | |
Pseudoephedrine | hsa04926 | Relaxin signaling pathway | 2.51E-03 | 6 | P62879, P18848, Q02930, P22694, P14780, P30679 | GNB2, ATF4, CREB5, PRKACB, MMP9, GNA15 | More | |
Pseudoephedrine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | |
Pseudoephedrine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | |
Pseudoephedrine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Pseudoephedrine | hsa04966 | Collecting duct acid secretion | 1.68E-02 | 2 | P02730, P00918 | SLC4A1, CA2 | More | |
Pseudoephedrine | hsa04970 | Salivary secretion | 1.91E-02 | 3 | P07550, P22694, P49913 | ADRB2, PRKACB, CAMP | More | |
Pseudoephedrine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | |
Pseudoephedrine | hsa05010 | Alzheimer disease | 6.51E-03 | 11 | O15239, P05496, P13073, Q00535, P0DP24, P01584, P18848, P67870, P05141, P28070, P43686 | NDUFA1, ATP5G1, COX4I1, CDK5, CALM2, IL1B, ATF4, CSNK2B, SLC25A5, PSMB4, PSMC4 | More | |
Pseudoephedrine | hsa05012 | Parkinson disease | 8.81E-03 | 9 | O15239, P13073, P05496, P05141, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX4I1, ATP5G1, SLC25A5, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | |
Pseudoephedrine | hsa05014 | Amyotrophic lateral sclerosis | 3.15E-02 | 10 | P20333, O15239, P13073, P05496, P18848, P28070, P43686, Q96CV9, P51991, Q9UBU9 | TNFRSF1B, NDUFA1, COX4I1, ATP5G1, ATF4, PSMB4, PSMC4, OPTN, HNRPA3, NXF1 | More | |
Pseudoephedrine | hsa05016 | Huntington disease | 2.68E-02 | 9 | O15239, P13073, P05496, P24928, P30876, P62487, P05141, P28070, P43686 | NDUFA1, COX4I1, ATP5G1, POLR2A, POLR2B, POLR2G, SLC25A5, PSMB4, PSMC4 | More | |
Pseudoephedrine | hsa05020 | Prion disease | 2.93E-04 | 15 | P01584, P46531, P11142, O15239, Q16718, O14521, P05496, P13073, P18848, P05141, P28070, P43686, P49841, P67870, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA1, NDUFA5, SDHD, ATP5G1, COX4I1, ATF4, SLC25A5, PSMB4, PSMC4, GSK3B, CSNK2B, MAPK14 | More | |
Pseudoephedrine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.80E-05 | 20 | P49841, P67870, O15239, Q16718, O14521, P13073, P05496, Q96CV9, P18848, Q13561, P05141, P20333, Q16539, Q00535, P01584, Q08752, P0DP24, Q13557, P28070, P43686 | GSK3B, CSNK2B, NDUFA1, NDUFA5, SDHD, COX4I1, ATP5G1, OPTN, ATF4, DCTN2, SLC25A5, TNFRSF1B, MAPK14, CDK5, IL1B, PPID, CALM2, CAMK2D, PSMB4, PSMC4 | More | |
Pseudoephedrine | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | |
Pseudoephedrine | hsa05034 | Alcoholism | 3.76E-02 | 2 | Q02930, P62879 | CREB5, GNB2 | More | |
Pseudoephedrine | hsa05133 | Pertussis | 4.94E-02 | 1 | P0C0L4 | C4A | More | |
Pseudoephedrine | hsa05135 | Yersinia infection | 3.36E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05143 | African trypanosomiasis | 6.60E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | |
Pseudoephedrine | hsa05144 | Malaria | 1.66E-04 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | |
Pseudoephedrine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | |
Pseudoephedrine | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
Pseudoephedrine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
Pseudoephedrine | hsa05161 | Hepatitis B | 2.69E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05163 | Human cytomegalovirus infection | 4.71E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.14E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05170 | Human immunodeficiency virus 1 infection | 3.81E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | |
Pseudoephedrine | hsa05218 | Melanoma | 1.07E-02 | 3 | P09619, Q9GZP0, Q02750 | PDGFRB, PDGFD, MAP2K1 | More | |
Pseudoephedrine | hsa05231 | Choline metabolism in cancer | 9.39E-03 | 4 | Q02750, P09619, Q9GZP0, O15245 | MAP2K1, PDGFRB, PDGFD, SLC22A1 | More | |
Pseudoephedrine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.02E-02 | 1 | Q13469 | NFATC2 | More | |
Pseudoephedrine | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | |
Pseudoephedrine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Pseudoephedrine | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | |
Pseudoephedrine | hsa05410 | Hypertrophic cardiomyopathy | 4.83E-02 | 2 | Q8WZ42, P63261 | TTN, ACTG1 | More | |
Pseudoephedrine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 3.10E-02 | 3 | Q8IZS8, P54284, P13612 | CACNA2D3, CACNB3, ITGA4 | More | |
Pseudoephedrine | hsa05414 | Dilated cardiomyopathy | 2.69E-03 | 6 | Q8IZS8, P54284, P13612, Q8WZ42, P26678, P63261 | CACNA2D3, CACNB3, ITGA4, TTN, PLN, ACTG1 | More | |
Pseudoephedrine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | |